Connect Biopharma Holdings Limited Ordinary Shares

CNTB XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

140M

Short interest (May 15)

2.0%

Net Short (Jun 03 ): 0.0%

Borrow Fee

1.86%

↓ 0.7%

Available Shares

700K

↑ 12.7%

Price Chart

Company Overview

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001835268

Asset Type: CS

Market Data

Market Cap: $135,372,283

Employees: 64

Status: Active

Short Interest

Current Borrow Fee 1.86%

Range: 1.85% - 1.86%

Available Shares 700K

Range: 400K - 650K

Recent Changes

Fee Change: ↓ 0.8%

Available Change: ↑ 13.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime